These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12214064)

  • 21. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraneuronal Aβ accumulation, amyloid plaques, and synapse pathology in Alzheimer's disease.
    Capetillo-Zarate E; Gracia L; Tampellini D; Gouras GK
    Neurodegener Dis; 2012; 10(1-4):56-9. PubMed ID: 22269167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease.
    Sensi SL; Rapposelli IG; Frazzini V; Mascetra N
    Exp Gerontol; 2008 May; 43(5):488-92. PubMed ID: 18068923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA; Davies DC; Kidd M; Duff K; Howlett DR
    Neurobiol Dis; 2003 Oct; 14(1):89-97. PubMed ID: 13678670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Avoidance of Apoptosis in Alzheimer's Disease.
    Nunomura A; Chiba S
    J Alzheimers Dis; 2000 Mar; 2(1):59-60. PubMed ID: 12214111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease.
    Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ
    Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commentary: Abeta N- Terminal Isoforms: Critical contributors in the course of AD pathophysiology.
    Tekirian TL
    J Alzheimers Dis; 2001 Apr; 3(2):241-248. PubMed ID: 12214065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
    Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
    Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer's disease.
    Hasegawa T; Ukai W; Jo DG; Xu X; Mattson MP; Nakagawa M; Araki W; Saito T; Yamada T
    J Neurosci Res; 2005 Jun; 80(6):869-76. PubMed ID: 15898106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
    Steiner H; Capell A; Leimer U; Haass C
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain.
    Frautschy SA; Horn DL; Sigel JJ; Harris-White ME; Mendoza JJ; Yang F; Saido TC; Cole GM
    J Neurosci; 1998 Oct; 18(20):8311-21. PubMed ID: 9763475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
    Kuzuhara S
    Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-amyloid, neuronal death and Alzheimer's disease.
    Carter J; Lippa CF
    Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease.
    Baranello RJ; Bharani KL; Padmaraju V; Chopra N; Lahiri DK; Greig NH; Pappolla MA; Sambamurti K
    Curr Alzheimer Res; 2015; 12(1):32-46. PubMed ID: 25523424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laminar specific loss of isocortical presenilin 1 immunoreactivity in Alzheimer's disease. Correlations with the amyloid load and the density of tau-positive neurofibrillary tangles.
    Colle MA; Duyckaerts C; Laquerrière A; Pradier L; Czech C; Checler F; Hauw JJ
    Neuropathol Appl Neurobiol; 2000 Apr; 26(2):117-23. PubMed ID: 10840274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization.
    LaFerla FM; Troncoso JC; Strickland DK; Kawas CH; Jay G
    J Clin Invest; 1997 Jul; 100(2):310-20. PubMed ID: 9218507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer's disease.
    Ohyagi Y
    Curr Alzheimer Res; 2008 Dec; 5(6):555-61. PubMed ID: 19075582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproic acid attenuates neuronal loss in the brain of APP/PS1 double transgenic Alzheimer's disease mice model.
    Long Z; Zheng M; Zhao L; Xie P; Song C; Chu Y; Song W; He G
    Curr Alzheimer Res; 2013 Mar; 10(3):261-9. PubMed ID: 23036022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.